These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7250552)

  • 1. Serum prednisolone levels in Crohn's disease and coeliac disease following oral prednisolone administration.
    Tanner AR; Halliday JW; Powell LW
    Digestion; 1981; 21(6):310-5. PubMed ID: 7250552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption of prednisolone in patients with Crohn's disease.
    Shaffer JA; Williams SE; Turnberg LA; Houston JB; Rowland M
    Gut; 1983 Mar; 24(3):182-6. PubMed ID: 6826099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-binding.
    Bergrem H; Opedal I
    Scand J Gastroenterol; 1983 May; 18(4):545-9. PubMed ID: 6669930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma propranolol levels in Crohn's disease and coeliac disease.
    Br Med J; 1977 Feb; 1(6058):443-4. PubMed ID: 837149
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease.
    Schneider RE; Babb J; Bishop H; Mitchard M; Hoare AM
    Br Med J; 1976 Oct; 2(6039):794-5. PubMed ID: 974614
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma propranolol levels in coeliac disease and Crohn's disease.
    Schneider RE; Babb J; Bishop H; Hoare AM; Hawkins CF
    Br Med J; 1976 Nov; 2(6047):1324. PubMed ID: 1000215
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of inflammatory bowel disease among coeliac disease patients in a Hungarian coeliac centre.
    Kocsis D; Tóth Z; Csontos ÁA; Miheller P; Pák P; Herszényi L; Tóth M; Tulassay Z; Juhász M
    BMC Gastroenterol; 2015 Oct; 15():141. PubMed ID: 26481725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of budesonide with prednisolone for active Crohn's disease.
    Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
    N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study.
    Goldacre MJ; Wotton CJ; Yeates D; Seagroatt V; Jewell D
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):297-304. PubMed ID: 18334873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Crohn's disease with positive serological markers for coeliac disease].
    Quirós Espigares N; Rubio Santiago J; Rodriguez Barrero S; Ortiz Tardío J
    An Pediatr (Barc); 2012 Oct; 77(4):283-4. PubMed ID: 22608599
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn's disease: a general population-based study.
    West J; Logan RF; Hubbard RB; Card TR
    Aliment Pharmacol Ther; 2006 Jan; 23(1):71-4. PubMed ID: 16393282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroproliferation in the mucosa is a feature of coeliac disease and Crohn's disease.
    Leonard N; Hourihane DO; Whelan A
    Gut; 1995 Dec; 37(6):763-5. PubMed ID: 8537045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to maize in patients with Crohn's disease, ulcerative colitis and coeliac disease.
    Davidson IW; Lloyd RS; Whorwell PJ; Wright R
    Clin Exp Immunol; 1979 Jan; 35(1):147-8. PubMed ID: 371884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The steroid resistance of Crohn's disease.
    Mingrone G; DeGaetano A; Pugeat M; Capristo E; Greco AV; Gasbarrini G
    J Investig Med; 1999 Jul; 47(6):319-25. PubMed ID: 10431487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid microclimate in coeliac and Crohn's disease: a model for folate malabsorption.
    Lucas ML; Cooper BT; Lei FH; Johnson IT; Holmes GK; Blair JA; Cooke WT
    Gut; 1978 Aug; 19(8):735-42. PubMed ID: 28271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The absorption and conjugation of methyldopa in patients with coeliac and Crohn's diseases during treatment.
    Renwick AG; Higgins V; Powers K; Smith CL; George CF
    Br J Clin Pharmacol; 1983 Jul; 16(1):77-83. PubMed ID: 6882626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma arachidonic acid-rich phospholipids in Crohn's disease: response to treatment.
    Pereira SP; Cassell TB; Engelman JL; Sladen GE; Murphy GM; Dowling RH
    Clin Sci (Lond); 1996 Oct; 91(4):509-12. PubMed ID: 8983878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of diminished factor XIII in Crohn's disease.
    Chamouard P; Grunebaum L; Wiesel ML; Sibilia J; Coumaros G; Wittersheim C; Baumann R; Cazenave JP
    Am J Gastroenterol; 1998 Apr; 93(4):610-4. PubMed ID: 9576457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
    Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.
    Novacek G; Kleinberger M; Vogelsang H; Moser G; Lochs H
    Z Gastroenterol; 1995 May; 33(5):251-4. PubMed ID: 7610692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.